A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer

被引：0
|
作者：
Taisuke Mori
Kenichi Hosokawa
Yoshiyuki Kinoshita
Ai Watanabe
Takeshi Yamaguchi
Haruo Kuroboshi
Yoshiko Kato
Jinsuke Yasuda
Hiroyuki Fujita
Yoshinori Nakata
Hideo Honjo
机构：
[1] Kyoto Prefectural University of Medicine,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2007年 / 12卷
关键词：
Ovarian cancer; Docetaxel; Paclitaxel; Toxicity; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：205 / 211
页数：6
相关论文
共 50 条
  • [1] A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer
    Mori, Taisuke
    Hosokawa, Kenichi
    Kinoshita, Yoshiyuki
    Watanabe, Ai
    Yamaguchi, Takeshi
    Kuroboshi, Haruo
    Kato, Yoshiko
    Yasuda, Ansuke
    Fujita, Hiroyuki
    Nakata, Yoshinori
    Honjo, Hideo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (03) : 205 - 211
  • [2] Is docetaxel-carboplatin an alternative to paclitaxel-carboplatin in ovarian cancer?
    Vasey, PA
    Coleman, R
    Eggleton, SPH
    Graham, J
    Fleming, D
    Paul, J
    Reed, NS
    Kaye, S
    BRITISH JOURNAL OF CANCER, 1999, 80 : 14 - 14
  • [3] Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
    Vasey, PA
    Jayson, GC
    Gordon, A
    Gabra, H
    Coleman, R
    Atkinson, R
    Parkin, D
    Paul, J
    Hay, A
    Kaye, SB
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (22): : 1682 - 1691
  • [4] Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
    Vasey, PA
    Atkinson, R
    Coleman, R
    Crawford, M
    Cruickshank, M
    Eggleton, P
    Fleming, D
    Graham, J
    Parkin, D
    Paul, J
    Reed, NS
    Kaye, SB
    BRITISH JOURNAL OF CANCER, 2001, 84 (02) : 170 - 178
  • [5] Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
    P A Vasey
    R Atkinson
    R Coleman
    M Crawford
    M Cruickshank
    P Eggleton
    D Fleming
    J Graham
    D Parkin
    J Paul
    N S Reed
    S B Kaye
    British Journal of Cancer, 2001, 84 : 170 - 178
  • [6] A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer
    Isonishi, Seiji
    Suzuki, Masaaki
    Nagano, Hiroaki
    Takagi, Koichiro
    Shimauchi, Masahito
    Kawabata, Masakiyo
    Ochiai, Kazuhiko
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (02) : 154 - 159
  • [7] A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer
    Takei, Y
    Suzuki, M
    Ohwada, M
    Saga, Y
    Kohno, T
    Machida, S
    Sato, I
    ONCOLOGY REPORTS, 2003, 10 (04) : 951 - 955
  • [8] Paclitaxel-carboplatin chemotherapy induced hematologic toxicities among epithelial ovarian cancer patients
    Charles, Afandi
    Dewayani, Birgitta M.
    Sahiratmadja, Edhyana
    Winarno, Gatot N. A.
    Susanto, Herman
    UNIVERSA MEDICINA, 2016, 35 (03) : 165 - 170
  • [9] Dose-finding study of docetaxel-Carboplatin in untreated advanced epithelial ovarian cancer (EOC)
    Vasey, PA
    Atkinson, R
    Coleman, R
    Eggleton, SPH
    Graham, J
    Paul, J
    Reed, NS
    Kave, SB
    ANNALS OF ONCOLOGY, 1998, 9 : 66 - 66
  • [10] A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer
    Adachi, S
    Ogasawara, T
    Ito, K
    Koyama, M
    Nagano, T
    Suzuki, A
    Yamada, T
    Nakata, Y
    Ozawa, M
    ONCOLOGY REPORTS, 2001, 8 (02) : 285 - 288
12345